Records containing: Stage IVB Prostate Cancer AJCC v8
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-06A Study of Erdafitinib in Castration-Resistant Prostate Cancer Patients Evaluating Markers of Bone Remodeling and FGF Signaling in Plasma and Bone Marrow
-
CLINICAL_TRIALS study record update · 2026-02-06Phase II Trial of Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (HP) Plus Enzalutamide for the Treatment of Selected Patients With Metastatic Castration-Resistant Prostate Cancer (TraPPer)
-
CLINICAL_TRIALS study record update · 2026-02-05A Single-Arm, Open-Label, Phase II Study of Systemic and Tumor Directed Therapy for Recurrent Oligometastatic M1 Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-02-05CASPAR - A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-02-04NCORP Tissue Procurement Protocol: An NCI Cancer Moonshot Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-28Vorinostat to Augment Response to 177Lutetium-PSMA-617 in the Treatment of Patients With PSMA-Low Metastatic Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-28Phase II Study of Talazoparib With Androgen Deprivation Therapy and Abiraterone in Castration Sensitive Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-22A Phase III Study of Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC), Stratified by Aggressive Variant Signature
-
CLINICAL_TRIALS study record update · 2026-01-20Advanced ChemoHormonal Therapy for Treatment Naïve Metastatic Prostate Cancer: Apalutamide and Abiraterone Acetate With Prednisone and Androgen Deprivation Therapy After Treatment With Docetaxel and Androgen Deprivation Therapy
-
CLINICAL_TRIALS study record update · 2026-01-14SPECTRA: Supraphysiological Androgen to Enhance Treatment Activity
-
CLINICAL_TRIALS study record update · 2026-01-14Efficacy of Ra-223 in PSMA PET Optimally Selected Patients
-
CLINICAL_TRIALS study record update · 2026-01-0968Ga-PSMA-11 PET in Patients With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-07Phase 2 Study of CJNJ-67652000 (Niraparib/Abiraterone Acetate Fixed-Dose Combination) and Prednisone for Metastatic Castration-Resistant Prostate Cancer Associated With SPOP Mutation With or Without Homologous Recombination Deficiency
-
CLINICAL_TRIALS study record update · 2025-12-22A Phase 2 Trial of ADT Interruption in Patients Responding Exceptionally to AR-Pathway Inhibitor in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): A-DREAM
-
CLINICAL_TRIALS study record update · 2025-12-09Addressing Health Literacy With a Tailored Survivorship Care Plan to Improve Access in Underserved African American Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2025-12-05Remote Perioperative Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
-
CLINICAL_TRIALS study record update · 2025-11-19A Phase 1b Study Evaluating Combinations With PSCA-Targeting Chimeric Antigen Receptor (CAR)-T Cells for Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-11-12A Phase 1b Clinical Trial: Improving Outcomes With Androgen Pathway Inhibitors by Targeting DNA Methyltransferase Activity
-
CLINICAL_TRIALS study record update · 2025-10-14Phase I/II Study to Evaluate the Safety and Tolerability of Avelumab in Combination With Other Anti-Cancer Therapies in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2025-10-01GENTleMEN: Genetic Testing for Men With Metastatic Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-10-01Radioligand Efficacy Comparison by Initial PSA-Response Outcome in Metastatic CRPC With Lutetium 177Lu PSMA RLT (RECIPROCAL)
-
CLINICAL_TRIALS study record update · 2025-09-15Multiple-Arm Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb20717 in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-09-11Minority-Inclusive Imaging Biomarker-Based End of Therapy Trial for 177Lu-PSMA-617, a Randomized De-Escalation Theranostic Trial for Metastatic Castrate Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-09-11Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-07-22A Phase 2 Study of BET Bromodomain Inhibitor ZEN-3694 in Combination With Enzalutamide Plus Pembrolizumab in Metastatic Castration Resistant Prostate Cancer